Teva Pharmaceutical Industries Ltd
Close on Oct 19, 2026Market cap $48.13BP/E 68.9Yield –
Teva Pharmaceutical Industries GAAP Operating Income / (Loss) Margin by Quarter
GAAP Operating Income / (Loss) Margin (%) (%)
Teva Pharmaceutical Industries GAAP Operating Income / (Loss) Margin: 16.2% in Q3 2026, down 3.5 pts from a year earlier.
Where the Q3 2026 figure comes from
“|| Operating margin | 16.2 % | 19.7 % | 9.1 % | 14.8 %”
Source: Form 8-K Earnings Release (0001171843-26-007054) ↗
Reported in SEC Form 10-K / Form 10-Q / Form 8-K Earnings Releases.
quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
Cite this data
StockData. (2026). Teva Pharmaceutical Industries GAAP Operating Income / (Loss) Margin (%), quarterly Q4 2021–Q3 2026 [Data set]. Compiled from Teva Pharmaceutical Industries SEC filings and investor materials. https://stockdatahq.com/stocks/teva/kpis/ng-gaap-op-margin
See every metric in the Teva Pharmaceutical Industries KPI table. Data updated Nov 10, 2026.
See a number that looks wrong?